True tracers: Comparing FDG with glucose and FLT with thymidine

Nuclear Medicine and Biology

Volumn 32, Issue 7, 2005, Pages 663-671

  Krohn, Kenneth A ^a   Mankoff, David A ^a   Muzi, Mark ^a   Link, Jeanne M ^a   Spence, Alexander M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

FDG; FLT; Glucose; Lumped constant; Metabolism; Thymidine

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THYMIDINE; TRACER;

ARTICLE; BLOOD ANALYSIS; CALIBRATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORRELATION ANALYSIS; DATA ANALYSIS; HALF LIFE TIME; MATHEMATICS; VALIDATION PROCESS;

EID: 27144473355     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.04.004     Document Type: Review

References (46)

1. M.E. Raichle Positron emission tomography tracer techniques J.W. Root K.A. Krohn Short-lived radionuclides in chemistry and biology 1981 American Chemical Society Washington (DC) 419 436
2. F. O'Sullivan Metabolic images from dynamic positron emission tomography studies Stat Methods Med Res 3 1 1994 87 101
3. 11C-labeled compounds J Nucl Med 33 1992 581 584
4. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem 28 1977 897 916
5. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man Circ Res 44 1979 127 137
6. 18F]FLT and positron emission tomography Nat Med 4 1998 1334 1336
7. M. Muzi, D.A. Mankoff, J.R. Grierson, J.M. Wells, H. Vesselle, and K.A. Krohn Kinetic modeling of 3′-deoxy-3′-fluorothymidine in somatic tumors: mathematical studies J Nucl Med 46 2005 371 380
8. 2 on cerebral blood volume, blood flow, and vascular mean transit time Stroke 5 1974 630 639
9. 18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors Clin Cancer Res 8 2002 3315 3323
10. M.A. Mintun, M.J. Welch, B.A. Siegel, C.J. Mathias, J.W. Brodack, and A.H. McGuire Breast cancer: PET imaging of estrogen receptors Radiology 169 1988 45 48
11. M.E. Raichle, M.J. Welch, R.L. Grubb Jr, C.S. Higgins, M.M. Ter-Pogossian, and K.B. Larson Measurement of regional substrate utilization rates by emission tomography Science 199 1978 986 987
12. 11C-d-glucose during stepped hypoglycemia Ann Neurol 38 1995 599 609
13. 11C]glucose and FDG: analysis of the FDG lumped constant J Nucl Med 39 1998 440 448
14. 11C]d-glucose J Cereb Blood Flow Metab 10 1990 467 483
15. T.A.D. Smith Facilitative glucose transporter expression in human cancer tissue Br J Biomed Sci 56 1999 285 292
16. T.A.D. Smith Mammalian hexokinases and their abnormal expression in cancer Br J Biomed Sci 57 2000 170 178
17. J.E. Wilson Brain hexokinase, the prototype ambiquitous enzyme Curr Top Cell Regul 16 1980 1 54
18. M.E. Phelps, S.C. Huang, E.J. Hoffman, C. Selin, L. Sokoloff, and D.E. Kuhl Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2deoxy-glucose: validation of method Ann Neurol 6 1979 371 388
19. 11C]deoxyglucose J Cereb Blood Flow Metab 5 1985 179 192
20. S.G. Hasselbalch, P.L. Madsen, G.M. Knudsen, S. Holm, and O.B. Paulson Calculation of the lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans J Cereb Blood Flow Metab 18 1998 154 160
21. 18F-fluorodeoxyglucose and glucose J Cereb Blood Flow Metab 21 2001 995 1002
22. 18F]2- fluoro-2-deoxy-d-glucose: a comparison of different analytical methods J Cereb Blood Flow Metab 7 1987 161 172
23. M.M. Graham, M. Muzi, A.M. Spence, F. O'Sullivan, T.K. Lewellen, and J.M. Link The FDG lumped constant in normal human brain J Nucl Med 43 2002 1157 1166
24. M. Muzi, S.D. Freeman, R.C. Burrows, R.W. Wiseman, J.M. Link, and K.A. Krohn Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging in human brain tumors Nucl Med Biol 28 2001 107 116
25. A.M. Spence, M. Muzi, M.M. Graham, F. O'Sullivan, J.M. Link, and T.K. Lewellen FDG and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome Clin Cancer Res 8 2002 971 979
26. 18F]-2-Fluoro-2-deoxyglucose transport kinetics as a function of extracellular glucose concentration in malignant glioma, fibroblast and macrophage cells in vitro Nucl Med Biol 31 2004 1 9
27. R.R. Russell, J.M. Mrus, J.I. Mommessin, and H. Taegtmeyer Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism J Clin Invest 90 1992 1972 1977
28. J.E. Wilson Hexokinases Rev Physiol Biochem Pharmacol 126 1995 65 198
29. S.-C. Huang Anatomy of SUV Nucl Med Biol 27 2000 643 646
30. D.A. Mankoff, M. Muzi, and K.A. Krohn Quantitative PET imaging to measure tumor response to therapy: what is the best method? Mol Imaging Biol 5 2003 281 285
31. D.A. Mankoff, L.K. Dunnwald, J.R. Gralow, G.K. Ellis, A. Charlop, and T.J. Lawton Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy J Nucl Med 43 2002 500 509
32. K.R. Zasadny, M. Tatsumi, and R.L. Wahl FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers Eur J Nucl Med Mol Imaging 30 2003 274 280
33. J. Tseng, L.K. Dunnwald, E.K. Schubert, J.M. Link, S. Minoshima, and M. Muzi [F-18]-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy J Nucl Med 45 2004 1829 1837
34. 11C]thymidine Proc Natl Acad Sci U S A 69 1972 988 992
35. D.A. Mankoff, A.F. Shields, M.M. Graham, J.M. Link, J.F. Eary, and K.A. Krohn Kinetic analysis of 2-[C-11]-thymidine PET imaging studies: compartmental model and mathematical analysis J Nucl Med 39 1998 1043 1055
36. 11C]-thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis Mol Imaging 3 2002 145 150
37. D.A. Mankoff, A.F. Shields, J.M. Link, M.M. Graham, M. Muzi, and L. Peterson Kinetic analysis of 2-[C-11]-thymidine PET imaging studies: validation studies J Nucl Med 40 1999 614 624
38. 11C]thymidine positron emission tomography in advanced intra-abdominal malignancies Cancer Res 62 2002 5698 5702
39. 18F]FLT for imaging of cellular proliferation in vivo Nucl Med Biol 27 2000 143 156
40. J.R. Grierson, J.L. Schwartz, M. Muzi, R. Jordan, and K.A. Krohn Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine (FLT) in proliferating A549 cells: validations for positron emission tomography (PET) Nucl Med Biol 31 2004 829 837
41. 3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines Nucl Med Biol 29 2002 281 287
42. J.A. Belt, N.M. Marina, D.A. Phelps, and C.R. Crawford Nucleoside transport in normal and neoplastic cells Adv Enzyme Regul 33 1993 235 252
43. 18F]-3′-deoxy-3′-fluoro- thymidine (FLT) for PET imaging of DNA biosynthesis in glioma patients J Nucl Med 45 2004 180P
44. B. Munch-Petersen, L. Cloos, G. Tyrsted, and S. Eriksson Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides J Biol Chem 266 1991 9032 9038
45. M. Muzi, H. Vesselle, J.R. Grierson, D.A. Mankoff, R.A. Schmidt, and L.M. Peterson Kinetic modeling of 3′-deoxy-3′-fluorothymidine in somatic tumors: validation in patients with lung cancer J Nucl Med 46 2005 272 284
46. 124I] iododeoxyuridine Cancer Res 60 2000 624 635